Role of Type I Interferon Signaling in Human Metapneumovirus Pathogenesis and Control of Viral Replication

Andrew K. Hastings(Bipar), John V. Williams(University of Wisconsin–Madison), Sebastian Joyce(Walther Cancer Foundation), Sharon J. Tollefson(Vanderbilt University), John J. Erickson(Vanderbilt University), Monika Johnson(Bipar), Jennifer E. Schuster(Children's Mercy Hospital), Kelli L. Boyd(Vanderbilt University Medical Center), Pavlo Gilchuk(AstraZeneca (Japan))
Journal of Virology
February 5, 2015
10.1128/jvi.03275-14
Cited by 43

Related Papers

Potently neutralizing and protective human antibodies against SARS-CoV-2
|Nature|2020|1.2k
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
|Cell Host & Microbe|2020|1.2k
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
|Nature Medicine|2021|1k
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19
|JAMA|2021|852
The Intracellular Sensor NLRP3 Mediates Key Innate and Healing Responses to Influenza A Virus via the Regulation of Caspase-1
|Immunity|2009|750